M&G Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-53,313
Closed -$3.36M 456
2022
Q4
$3.36M Buy
53,313
+24,236
+83% +$1.39M 0.02% 246
2022
Q3
$1.45K Hold
29,077
0.01% 271
2022
Q2
$1.72K Buy
29,077
+1,446
+5% +$79.7K 0.01% 290
2022
Q1
$1.46K Hold
27,631
﹤0.01% 334
2021
Q4
$1.69K Buy
+27,631
New +$1.64M ﹤0.01% 308

Other funds holding PBH

M&G Investment Management's PBH Position: Q1 2023 in Review

M&G Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2023, closing a stake of 53,313 shares — an estimated $3.36M sold.

M&G Investment Management first reported a position in PBH in Q4 2021 and held it in 5 quarters. The position peaked at $3.36M in Q4 2022. 283 funds tracked by Wall St. Rank hold PBH as of Q1 2023.

  • M&G Investment Management reported no remaining Prestige Consumer Healthcare position as of Q1 2023 after selling out during the quarter.
  • M&G Investment Management sold 53,313 Prestige Consumer Healthcare shares in Q1 2023, an estimated $3.36M.
  • M&G Investment Management first reported a position in Prestige Consumer Healthcare in Q4 2021 and held it in 5 quarters.
  • M&G Investment Management's Prestige Consumer Healthcare position peaked at $3.36M in Q4 2022.
  • 283 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2023.

Based on M&G Investment Management's 13F filing for Q1 2023, filed 11 May 2023.